Can methyldopa affect the onset or progression of coronary artery disease and what is its role in improving cardiac outcomes?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa is primarily used for hypertension, not directly influencing coronary artery disease progression or improving cardiac outcomes.